Literature DB >> 1980215

A new form of guanylyl cyclase is preferentially expressed in rat kidney.

P S Yuen1, L R Potter, D L Garbers.   

Abstract

On the basis of the conserved amino acid sequences of the catalytic domain of both soluble and plasma membrane forms of guanylyl cyclase, we have used the polymerase chain reaction to identify a new form of guanylyl cyclase that is expressed principally in kidney. The cDNA for this new form (GC-S beta 2) codes for a 76.3-kDa protein, which most closely resembles a 70-kDa subunit (GC-S beta 1) of the lung soluble guanylyl cyclase. The mRNA for GC-S beta 1 is preferentially expressed in lung and brain, whereas GC-S beta 2 mRNA is more abundant in kidney and liver. An 86 amino acid carboxyl-terminal region extends beyond the C-terminus of GC-S beta 1 and contains a consensus sequence (-C-V-V-L) for isoprenylation/carboxymethylation. This is the first demonstration of heterogeneity among the heterodimeric forms of guanylyl cyclase and suggests differential regulation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1980215     DOI: 10.1021/bi00501a002

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  29 in total

1.  RNA: a method to specifically inhibit PCR amplification of known members of a multigene family by degenerate primers.

Authors:  P S Yuen; K M Brooks; Y Li
Journal:  Nucleic Acids Res       Date:  2001-03-15       Impact factor: 16.971

Review 2.  Isoforms of NO-sensitive guanylyl cyclase.

Authors:  Michael Russwurm; Doris Koesling
Journal:  Mol Cell Biochem       Date:  2002-01       Impact factor: 3.396

3.  Properties of NO-activated guanylyl cyclases expressed in cells.

Authors:  Barry J Gibb; Victoria Wykes; John Garthwaite
Journal:  Br J Pharmacol       Date:  2003-07       Impact factor: 8.739

4.  Polymerase chain reaction localization of constitutive nitric oxide synthase and soluble guanylate cyclase messenger RNAs in microdissected rat nephron segments.

Authors:  Y Terada; K Tomita; H Nonoguchi; F Marumo
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

Review 5.  Receptor guanylyl cyclases.

Authors:  S K Wong; D L Garbers
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

6.  Characterization of soluble platelet guanylyl cyclase with peptide antibodies.

Authors:  F Guthmann; B Mayer; D Koesling; W R Kukovetz; E Böhme
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-11       Impact factor: 3.000

7.  Soluble Guanylyl Cyclases in Invertebrates: Targets for NO and O(2).

Authors:  David B Morton; Anke Vermehren
Journal:  Adv Exp Biol       Date:  2007

8.  The beta2 subunit inhibits stimulation of the alpha1/beta1 form of soluble guanylyl cyclase by nitric oxide. Potential relevance to regulation of blood pressure.

Authors:  G Gupta; M Azam; L Yang; R S Danziger
Journal:  J Clin Invest       Date:  1997-09-15       Impact factor: 14.808

Review 9.  Mechanisms of action of nitrates.

Authors:  K E Torfgård; J Ahlner
Journal:  Cardiovasc Drugs Ther       Date:  1994-10       Impact factor: 3.727

10.  Mechanisms of tolerance to sodium nitroprusside in rat cultured aortic smooth muscle cells.

Authors:  A Papapetropoulos; C Y Go; F Murad; J D Catravas
Journal:  Br J Pharmacol       Date:  1996-01       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.